Scenario.press - libera espressione Scenario.press - libera espressione
Результаты поиска
Все результаты
  • Вступить
    Войти
    Регистрация
    Поиск
    Ночной режим

Поиск

Знакомьтесь и заводите новых друзей

  • Новости
  • ИССЛЕДОВАТЬ
  • Страницы
  • Группы
  • Мероприятия
  • Статьи пользователей
  • Marketplace
  • Funding
  • Offers
  • Jobs
  • Courses
  • Кинозал
  • Разработчики
  • Записей
  • Статьи пользователей
  • Пользователи
  • Страницы
  • Группы
  • Мероприятия
  • jerry001 добавлена новая статья Networking
    2025-01-30 06:07:10 -
    Biosimilar Monoclonal Antibodies Market to reach Blatant Growth in Coming years by 2031 | Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz)
    Biosimilar Monoclonal Antibodies Market report has recently added by Analytic Insights Hub which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. Biosimilar Monoclonal Antibodies Market study goes...
    0 Комментарии 0 Поделились 3Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • akshayg добавлена новая статья Networking
    2025-09-01 10:22:09 -
    Pegfilgrastim Biosimilar Market, Trends, Covid-19 Impact Analysis, Size And Growth Estimation by Fact MR
    As per Fact.MR’s latest industry analysis, the global pegfilgrastim biosimilar market stands at US$ 1.41 billion in 2023. Global demand for pegfilgrastim biosimilars is projected to reach a market valuation of US$ 3.66 billion by 2033-end, increasing at a CAGR of 10% over the next ten years.This substantial growth is driven by the rising incidence of cancer worldwide, increasing adoption...
    0 Комментарии 0 Поделились 309 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • jerry001 добавлена новая статья Networking
    2025-01-21 09:42:08 -
    Psoriasis Biosimilar Market to reach Blatant Growth in Coming years by 2031 | Merck KGaA, Gyros Protein Technologies AB
    Psoriasis Biosimilar Market report has recently added by Analytic Insights Hub which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. Psoriasis Biosimilar Market study goes into great detail on the...
    0 Комментарии 0 Поделились 2Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • jamessmithjimmy12 добавлена новая статья Health
    2025-05-13 04:44:09 -
    Biosimilar Market Size, Share, Trends, Business Strategies and Opportunities with Key Players Analysis 2033
    IMARC Group, a leading market research company, has recently releases report titled “Biosimilar Market Size, Share, Trends and Forecast by Molecule, Indication, Manufacturing Type, and Region, 2025-2033”. The study provides a detailed analysis of the industry, including the global biosimilar market trends, share, size and growth forecast. The report also includes competitor and...
    0 Комментарии 0 Поделились 2Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • riyajstraits добавлена новая статья Другое
    2025-09-19 06:44:30 -
    Key Market Drivers for Biosimilar Monoclonal Antibodies Market: Forecast to 2033
    Biosimilar Monoclonal Antibodies Market Overview Imagine a world where cutting-edge tech transforms industries, boosts efficiency, and opens doors to endless innovation. That's the promise of the market, and according to Straits Research, it's on a rocket ship trajectory with a robust The global biosimilar monoclonal antibodies market size was valued at USD 14.92 Billion in...
    0 Комментарии 0 Поделились 361 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
© 2025 Scenario.press - libera espressione Russian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Конфиденциальность Business Model Donations Свяжитесь с нами Каталог